VR Logo

Ocuphire Pharma Inc. (OCUP) download report


Healthcare | Biotechnology & Pharma Research

Ocuphire Pharma Inc. (OCUP) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.

IPO Date: 23-May-2005

Founder, CEO, Pres, Treasurer & Vice Chair of the Board: Ms. Mina Patel Sooch M.B.A., MBA

VP of Fin. & Principal Accounting Officer: Ms. Amy Zaremba Rabourn C.P.A., CPA, MAcc

Listing: NASDAQ: OCUP

Country: United States

Headquarters: Farmington Hills, MI

Website: https://www.ocuphire.com

Key Facts

Market cap: $36.60 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-24.27 Mln

Cash: $19.38 Mln

Total Debt: $0.22 Mln

Insider's Holding: 3.66%

Liquidity: Low

52 Week range: $1.78 - 5.50

Shares outstanding: 19,364,400

Stock Performance

Time Period Ocuphire Pharma (OCUP) S&P BSE Sensex S&P Small-Cap 600
YTD-48.53-8.79-19.61
1 month-8.13-4.72-9.38
3 months-40.92-12.34-15.04
1 Year-60.821.24-17.73
3 Years-54.9510.015.82
5 Years-56.9711.235.47
10 Years-37.2111.779.50
As on 05-Jul-2022
Year Ocuphire Pharma (OCUP) S&P Small-Cap 600 S&P BSE Sensex
2021-42.5325.2721.99
2020-15.059.5715.75
2019-82.8920.8614.38
2018-53.77-9.705.87
201742.3511.7327.91
2016-60.9124.741.95
2015-48.14-3.36-5.03